ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2515

Low Density Lipoprotein Receptor Deficiency Results in Osteophyte Formation During Experimental Osteoarthritis Which Is Enhanced Under High Cholesterol Conditions

Wouter de Munter, Birgitte Walgreen, Monique M. Helsen, Annet W. Sloëtjes, Wim B. van den Berg and Peter L.E.M. van Lent, Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cholesterol, osteoarthritis and osteophytosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint: Regulation of Bone Cells

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Synovial macrophages are involved in osteophyte formation during experimental collagenase-induced osteoarthritis (OA). Accumulated LDL can be oxidized in an inflammatory environment such as OA and be taken up by scavenger receptors of macrophages, changing the macrophage fenotype. The effect of LDLr deficiency and cholesterol accumulation on OA pathology was investigated using an experimental OA model.

Methods:  LDLr deficient (LDLr-/-) mice and their wild type (WT) controls received either a high cholesterol or control diet for 120 days. Experimental OA was induced by intra-articular injection of collagenase on day 84 and 86. Paraffin sections of total knee joints were stained with safranin O – fast green or haematoxylin – eosin to determine OA development. Thickening of the synovial lining layer was measured using an arbitrary scale (0 to 3). Cartilage destruction was determined in four cartilage surfaces of the knee joint (lateral and media femur and tibia) using the OA score developed by Pritzker et al.(2006), adapted by us for mice (0 to 30). Size of osteophyte formation was determined using image analysis by measuring osteophyte surface areas at the margins of the tibial plateau and femoral condyles. Data are depicted as mean ± SD.

Results:  WT mice receiving a normal diet developed moderate cartilage destruction (6.1 ± 2.6), synovial thickening (1.4 ± 0.6), and osteophyte formation (56.5 µm2 ± 94.6). Both LDLr-/- groups showed comparable cartilage destruction and showed no change in bodyweight (23.99 g ± 1.85). WT mice receiving a cholesterol-rich diet showed increased bodyweight compared to the other three groups (28.82 g ± 4.81; p<0.0001), however, no significantly increased cartilage destruction was observed. No differences between the four groups were found regarding synovial thickening. LDL levels were significantly higher in LDLr-/- mice compared to WT mice (7.33 mmol/L ± 1.44 and 0.54 mmol/L ± 0.11 respectively; p<0.0001), which was additionally increased by a cholesterol-rich diet (38.73 mmol/L ± 9.84; p<0.0001). At the tibial plateau, LDL-/- mice showed almost a 4 times increase of osteophyte formation compared to WT mice (206.3 µm2 ± 196.3; p<0.05). When receiving a cholesterol-rich diet, osteophyte formation at the lateral side of the tibial plateau in LDLr-/- mice further increased from 107.0 µm2 ± 156.0 to 309.4 µm2 ± 132.0 (p<0.05).

Conclusion:  Enhanced LDL levels correlate with increased osteophyte formation in LDLr-/- mice, suggesting a pathologic role of LDL accumulation during OA.


Disclosure:

W. de Munter,
None;

B. Walgreen,
None;

M. M. Helsen,
None;

A. W. Sloëtjes,
None;

W. B. van den Berg,
None;

P. L. E. M. van Lent,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/low-density-lipoprotein-receptor-deficiency-results-in-osteophyte-formation-during-experimental-osteoarthritis-which-is-enhanced-under-high-cholesterol-conditions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology